Holen Sie sich die Stockscreener-App
11.77
3.06%
0.35
Vorhandelsmarkt:
12.00
0.23
+1.95%
Schlusskurs vom Vortag:
$11.42
Offen:
$11.43
24-Stunden-Volumen:
543.71K
Relative Volume:
1.07
Marktkapitalisierung:
$551.81M
Einnahmen:
$502.79M
Nettoeinkommen (Verlust:
$23.71M
KGV:
23.54
EPS:
0.5
Netto-Cashflow:
$6.35M
1W Leistung:
+0.77%
1M Leistung:
-5.16%
6M Leistung:
-40.25%
1J Leistung:
-47.99%
1-Tages-Spanne:
$11.43
$12.03
1-Wochen-Bereich:
$11.18
$12.03
52-Wochen-Spanne:
$10.14
$25.13
Core Laboratories Inc Stock (CLB) Company Profile
Firmenname
Core Laboratories Inc
Sektor
Telefon
713-328-2673
Adresse
6316 WINDFERN ROAD, HOUSTON
Vergleichen Sie CLB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
11.77 | 547.59M | 502.79M | 23.71M | 6.35M | 0.50 |
|
SLB
Schlumberger Ltd
|
34.35 | 52.31B | 35.48B | 4.09B | 4.52B | 2.92 |
|
BKR
Baker Hughes Company
|
40.02 | 38.63B | 27.84B | 2.93B | 2.01B | 2.93 |
|
TS
Tenaris S A Adr
|
37.77 | 19.59B | 13.09B | 2.65B | 2.52B | 4.5936 |
|
HAL
Halliburton Co
|
21.39 | 18.39B | 22.56B | 2.10B | 2.34B | 2.39 |
|
FTI
Technipfmc Plc
|
32.42 | 14.32B | 9.27B | 827.80M | 1.24B | 1.90 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-06-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2023-04-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-09-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-07-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-11-11 | Bestätigt | Cowen | Market Perform |
| 2020-10-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-09-29 | Hochstufung | ABN Amro | Sell → Hold |
| 2020-07-16 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-01-31 | Bestätigt | Cowen | Market Perform |
| 2020-01-30 | Fortgesetzt | Johnson Rice | Buy |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2019-12-31 | Bestätigt | Cowen | Market Perform |
| 2019-07-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | Hochstufung | Tudor Pickering | Hold → Buy |
| 2018-12-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2018-11-01 | Hochstufung | ABN Amro | Sell → Buy |
| 2018-10-29 | Bestätigt | Cowen | Market Perform |
Alle ansehen
Core Laboratories Inc Aktie (CLB) Neueste Nachrichten
Signaturefd LLC Reduces Holdings in Core Laboratories Inc. (NYSE:CLB) - Defense World
Core Laboratories Inc. Stock Analysis and ForecastExceptional ROI - Autocar Professional
What analysts say about Core Laboratories Inc. stockFree Trend-Following Techniques - jammulinksnews.com
Why Core Laboratories Inc. stock attracts strong analyst attentionElite Investor Club - Newser
Is Core Laboratories Inc. a good long term investmentFree Stock Market Return Analysis - jammulinksnews.com
Watch These 4 Energy Stocks for Q2 Earnings: Beat or Miss? - TradingView
Core Laboratories (CLB) Falls Amid a Difficult Time for the Oilfield Services Sector - MSN
Core Laboratories Inc expected to post earnings of 19 cents a shareEarnings Preview - TradingView
Core Laboratories Inc. shares rise 1.05% intraday as Nasdaq, S&P hit record levels. - AInvest
Why These Energy Stocks are Losing This Week - Insider Monkey
Here’s Why Core Laboratories (CLB) Traded Lower in Q2 - Insider Monkey
Core Laboratories CLB 2025Q2 Earnings Preview Upside Potential Driven by Strategic Partnerships - AInvest
What drives Core Laboratories Inc. stock priceHigh-yield capital appreciation - PrintWeekIndia
Core Laboratories (CLB) to Release Quarterly Earnings on Wednesday - MarketBeat
Core Laboratories to Post Q2 Earnings: Key Metrics to Watch - MSN
Rice Hall James & Associates LLC Raises Stake in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Core Laboratories (NYSE:CLB) Price Target Cut to $12.00 by Analysts at Stifel Nicolaus - MarketBeat
When is the best time to buy Core Laboratories Inc. stockFree Stock Market Practical Discussion Forums - Newser
Core Laboratories Inc. (NYSE:CLB) Shares Bought by Principal Financial Group Inc. - Defense World
Stifel Nicolaus Issues Pessimistic Forecast for Core Laboratories (NYSE:CLB) Stock Price - Defense World
What analysts say about Core Laboratories Inc. stock outlookFree Popular Stock Recommendations - Newser
How Core Laboratories Inc. stock performs during market volatilityPredictable High Return Trades - beatles.ru
Critical Comparison: Core Laboratories (NYSE:CLB) & Freestone Resources (OTCMKTS:FSNR) - Defense World
Stifel Adjusts Price Target for Core Laboratories (CLB) | CLB St - GuruFocus
Core Laboratories (CLB) Receives Lower Price Target from Stifel - GuruFocus
Core Laboratories (CLB) Projected to Release Quarterly Earnings on Wednesday - Defense World
Finanzdaten der Core Laboratories Inc-Aktie (CLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.23%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):